400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Neuronal Signaling / MAO / (S)-Rasagiline mesylate/(S)-雷沙吉兰甲磺酸
CAS No.: 202464-88-8
Synonyms: TVP1022 mesylate;S-PAI mesylate;(S)-Rasagiline Mesylate
TVP1022 mesylate is the S-isomer of rasagiline, which is an anti-Parkinson drug, appears to have the same neuroprotective activity as the R-isomer, but is 1000-fold less active as an MAO-B inhibitor.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT00203125 | Parkinson's Disease | Phase 3 | Completed | - | - |
NCT01723228 | Parkinson's Disease | Phase 4 | Completed | - | - |
NCT00104273 | Dementia Alzh... more >>eimer's Disease Collapse << | Phase 2 | Completed | - | - |
实验方案
技术信息
CAS号 | 202464-88-8 | 储存条件 |
|
|
分子式 | C13H17NO3S | 运输 | 蓝冰 | |
分子量 | 267.34 | 别名 | TVP1022 mesylate;S-PAI mesylate;(S)-Rasagiline Mesylate;(S)-雷沙吉兰甲磺酸 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT00203125 | Parkinson's Disease | Phase 3 | Completed | - | - |
NCT01723228 | Parkinson's Disease | Phase 4 | Completed | - | - |
NCT00104273 | Dementia Alzh... more >>eimer's Disease Collapse << | Phase 2 | Completed | - | - |
NCT00256204 | Parkinson's Disease | Phase 3 | Completed | - | - |
NCT00399477 | Parkinson's Disease | Phase 4 | Completed | - | - |
NCT00256204 | - | - | Completed | - | - |
NCT00936676 | - | - | Completed | - | - |
NCT01879748 | Parkinson's Disease | Phase 1 | Completed | - | United States, California ... more >> Teva Investigational Site 10738 Glendale, California, United States Collapse << |
NCT01723228 | - | - | Completed | - | - |
NCT00203034 | Parkinson's Disease | Phase 3 | Completed | - | United States, Illinois ... more >> Rush - Presbyterian St. Luke's Medical Center Chicago, Illinois, United States, 60612 United States, New York Columbia - Presbyterian Medical Center New York, New York, United States, 10032 University of Rochester Rochester, New York, United States, 14642 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 Collapse << |
NCT01032486 | - | - | Completed | - | - |
NCT00203060 | Parkinson's Disease | Phase 3 | Completed | - | - |
NCT00203177 | Parkinson's Disease | Phase 3 | Completed | - | United States, California ... more >> Margolin Brain Institute Fresno, California, United States, 93720 United States, Georgia Emory University Atlanta, Georgia, United States, 30329 United States, Illinois Rush - Presbyterian St. Luke's Medical Center Chicago, Illinois, United States, 60612 United States, Nebraska Creighton University Omaha, Nebraska, United States, 68131 United States, New York Long Island Jewish Medical Center New Hyde Park, New York, United States, 11040 University of Rochester Rochester, New York, United States, 14642 United States, Pennsylvania Pennsylvania Hospital Philadelphia, Pennsylvania, United States, 19107 Canada, Quebec CHUM-Hotel-Dieu Montreal, Quebec, Canada, H2w1T8 Collapse << |
NCT00203138 | Parkinson's Disease | Phase 3 | Completed | - | - |
NCT00977665 | Multiple System Atrophy | Phase 2 | Completed | - | - |
NCT00977665 | - | - | Completed | - | - |
NCT00203164 | Parkinson's Disease | Phase 3 | Completed | - | United States, California ... more >> Margolin Brain Institute Fresno, California, United States, 93720 United States, Illinois Rush - Presbyterian St. Luke's Medical Center Chicago, Illinois, United States, 60612 United States, Nebraska Creighton University Omaha, Nebraska, United States, 68131 United States, New York Long Island Jewish Medical Center New Hyde Park, New York, United States, 11040 University of Rochester Rochester, New York, United States, 14642 United States, Pennsylvania Pennsylvania Hospital Philadelphia, Pennsylvania, United States, 19107 Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网